Brunner M, Pernerstorfer T, Mayer B X, Eichler H G, Müller M
Department of Clinical Pharmacology, University of Vienna Medical School, Austria.
Crit Care Med. 2000 Jun;28(6):1754-9. doi: 10.1097/00003246-200006000-00009.
Therapeutic failure of antibiotic therapy has been ascribed to pharmacokinetic alterations in compromised patient populations. The present study, therefore, aimed at examining the influences of cardiac surgery and intensive care procedures on the postoperative target site distribution of piperacillin. For this purpose, the penetration of piperacillin to the interstitial space fluid, the relevant target site for most bacterial infections, was compared between patients after aortic valve replacement and healthy volunteers.
Comparative study in two study populations.
The intensive care unit and research ward of a university hospital.
The study population included six otherwise healthy patients scheduled to undergo aortic valve replacement and a control group of six healthy male volunteers.
After the administration of a single i.v. infusion of 4.0 g piperacillin, free piperacillin concentrations were measured in the interstitium of skeletal muscle and subcutaneous tissue by in vivo microdialysis and in venous serum. Piperacillin concentrations were assayed with reversed phase high-performance liquid chromatography.
Interstitial piperacillin concentrations in muscle and subcutaneous adipose tissue were significantly lower in patients compared with volunteers with the area under the curve for the interstitium/area under the curve for serum concentration ratios ranging from 0.25 to 0.27 and from 0.43 to 1.22 in patients and volunteers, respectively (p < .05 between groups). The terminal elimination half-life was markedly prolonged in patients, leading to a concomitant increase in t > minimal inhibitory concentration (MIC) values, the relevant surrogate for therapeutic success of therapy with beta-lactam antibiotics, for strains with MIC50 <4 microg/mL. For strains with MIC50 >20 microl/mL, however, inadequate target site concentrations were attained in the patient population.
During the postoperative and intensive care periods, target site concentrations of piperacillin are markedly altered and decreased. This may also be true for other antibiotic agents and may have clinical implications in that current dosing guidelines may result in inadequate target site concentrations for high-MIC strains. Conceivably, this could lead to therapeutic failure in some patients.
抗生素治疗的失败被归因于身体状况不佳患者群体的药代动力学改变。因此,本研究旨在考察心脏手术和重症监护程序对哌拉西林术后靶位分布的影响。为此,比较了主动脉瓣置换术后患者与健康志愿者中哌拉西林向间质液(大多数细菌感染的相关靶位)的渗透情况。
在两个研究群体中进行的比较研究。
一所大学医院的重症监护病房和研究病房。
研究群体包括6名计划接受主动脉瓣置换的其他方面健康的患者以及一个由6名健康男性志愿者组成的对照组。
单次静脉输注4.0 g哌拉西林后,通过体内微透析法在骨骼肌和皮下组织的间质以及静脉血清中测量游离哌拉西林浓度。采用反相高效液相色谱法测定哌拉西林浓度。
与志愿者相比,患者肌肉和皮下脂肪组织中的间质哌拉西林浓度显著降低,患者和志愿者的间质曲线下面积/血清浓度曲线下面积比值分别为0.25至0.27和0.43至1.22(组间p<0.05)。患者的终末消除半衰期显著延长,导致对于MIC50<4μg/mL的菌株,t>最低抑菌浓度(MIC)值(β-内酰胺类抗生素治疗成功的相关替代指标)随之增加。然而,对于MIC50>20μg/mL的菌株,患者群体中未达到足够的靶位浓度。
在术后和重症监护期间,哌拉西林的靶位浓度显著改变并降低。其他抗生素药物可能也是如此,这可能具有临床意义,即当前的给药指南可能导致高MIC菌株的靶位浓度不足。可以想象,这可能会导致一些患者治疗失败。